PURPOSE: Head and neck cancer (HNC) patients experience multiple physical and psychosocial symptoms associated with their cancer treatment. The Easing and Alleviating Symptoms during Treatment (EASE) study utilized a mixed methods design to examine the feasibility of a tailored telephone-based coping and stress management intervention to improve symptom management and psychosocial care among HNC patients. METHODS: An Embedded Correlational Mixed Methods Design was utilized to answer two research questions: (1) is the EASE intervention feasible? and (2) Did EASE participants report improvements in psychosocial outcomes after completion of the EASE intervention? HNC patients were assessed at baseline and 3 months. Psychosocial measures included cancer-specific distress, pain, social support, and quality of life. Project records and exit interviews were conducted to assess acceptability and satisfaction with the intervention. RESULTS: The mean age of the participants was 60 years (SD = 9.5), 76 % were male, 47 % married/partnered, and 57 % had a history of tobacco use. Of the 24 participants who were enrolled, 16 completed the intervention. Participants and telephone counselors reported high levels of satisfaction. Although the small sample size and lack of a control group limit our ability to assess the efficacy of the intervention, our findings suggest that the intervention helped to buffer the negative emotional and physical impact of cancer treatment. CONCLUSIONS: This pilot study demonstrated that the EASE intervention is feasible and acceptable to HNC cancer patients undergoing treatment. The study findings revealed some challenges of implementing a psychosocial intervention in HNC patients and inform future intervention studies with this population.
PURPOSE: Head and neck cancer (HNC) patients experience multiple physical and psychosocial symptoms associated with their cancer treatment. The Easing and Alleviating Symptoms during Treatment (EASE) study utilized a mixed methods design to examine the feasibility of a tailored telephone-based coping and stress management intervention to improve symptom management and psychosocial care among HNC patients. METHODS: An Embedded Correlational Mixed Methods Design was utilized to answer two research questions: (1) is the EASE intervention feasible? and (2) Did EASE participants report improvements in psychosocial outcomes after completion of the EASE intervention? HNC patients were assessed at baseline and 3 months. Psychosocial measures included cancer-specific distress, pain, social support, and quality of life. Project records and exit interviews were conducted to assess acceptability and satisfaction with the intervention. RESULTS: The mean age of the participants was 60 years (SD = 9.5), 76 % were male, 47 % married/partnered, and 57 % had a history of tobacco use. Of the 24 participants who were enrolled, 16 completed the intervention. Participants and telephone counselors reported high levels of satisfaction. Although the small sample size and lack of a control group limit our ability to assess the efficacy of the intervention, our findings suggest that the intervention helped to buffer the negative emotional and physical impact of cancer treatment. CONCLUSIONS: This pilot study demonstrated that the EASE intervention is feasible and acceptable to HNC cancerpatients undergoing treatment. The study findings revealed some challenges of implementing a psychosocial intervention in HNC patients and inform future intervention studies with this population.
Authors: P U Huguenin; D Taussky; K Moe; A Meister; B Baumert; U M Lütolf; C Glanzmann Journal: Int J Radiat Oncol Biol Phys Date: 1999-08-01 Impact factor: 7.038
Authors: Frank J Penedo; Ivan Molton; Jason R Dahn; Biing-Jiun Shen; Dave Kinsinger; Lara Traeger; Scott Siegel; Neil Schneiderman; Michael Antoni Journal: Ann Behav Med Date: 2006-06
Authors: Edward L Nelson; Lari B Wenzel; Kathryn Osann; Aysun Dogan-Ates; Nissa Chantana; Astrid Reina-Patton; Amanda K Laust; Kevin P Nishimoto; Alexandra Chicz-DeMet; Nefertiti du Pont; Bradley J Monk Journal: Clin Cancer Res Date: 2008-04-01 Impact factor: 12.531
Authors: Alfred C Marcus; Kathleen M Garrett; David Cella; Lari Wenzel; Marianne J Brady; Diane Fairclough; Meredith Pate-Willig; Denise Barnes; Susan Powell Emsbo; Brenda C Kluhsman; Lori Crane; Scot Sedlacek; Patrick J Flynn Journal: Psychooncology Date: 2010-09 Impact factor: 3.894
Authors: Carrie A Karvonen-Gutierrez; David L Ronis; Karen E Fowler; Jeffrey E Terrell; Stephen B Gruber; Sonia A Duffy Journal: J Clin Oncol Date: 2008-06-01 Impact factor: 44.544
Authors: Ingrid C Cnossen; Cornelia F van Uden-Kraan; Rico N P M Rinkel; Ijke J Aalders; Cees J T de Goede; Remco de Bree; Patricia Doornaert; Derek H F Rietveld; Johannes A Langendijk; Birgit I Witte; C Rene Leemans; Irma M Verdonck-de Leeuw Journal: J Med Internet Res Date: 2014-03-06 Impact factor: 5.428
Authors: Anna Cox; Grace Lucas; Afrodita Marcu; Marianne Piano; Wendy Grosvenor; Freda Mold; Roma Maguire; Emma Ream Journal: J Med Internet Res Date: 2017-01-09 Impact factor: 5.428
Authors: K M Graner; G S Rolim; A B A Moraes; C R Padovani; M A Lopes; A R Santos-Silva; A T A Ramos-Cerqueira Journal: Support Care Cancer Date: 2015-11-27 Impact factor: 3.359